BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
McKesson
QuintilesIMS
Express Scripts
Harvard Business School
Colorcon
Daiichi Sankyo
Julphar
Medtronic

Generated: January 21, 2018

DrugPatentWatch Database Preview

DILTIAZEM HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diltiazem hydrochloride and what is the scope of diltiazem hydrochloride freedom to operate?

Diltiazem hydrochloride
is the generic ingredient in eleven branded drugs marketed by Valeant Intl, Biovail, Actavis Labs Fl Inc, Allergan Sales Llc, Apotex, Actavis Elizabeth, Mylan, Nesher Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Sun Pharma Global, Teva, Valeant Pharms North, Zydus Pharms Usa Inc, Apotex Inc, Biovail Labs Intl, Akorn Inc, Athenex Inc, Hikma Farmaceutica, Hospira, Intl Medication, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Apothecon, Chartwell Molecules, Ivax Sub Teva Pharms, and Teva Pharms, and is included in forty-eight NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Diltiazem hydrochloride has twenty-two patent family members in eleven countries.

There are twenty-six drug master file entries for diltiazem hydrochloride. Forty-seven suppliers are listed for this compound.
Summary for DILTIAZEM HYDROCHLORIDE
Pharmacology for DILTIAZEM HYDROCHLORIDE

US Patents and Regulatory Information for DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail Labs Intl CARDIZEM diltiazem hydrochloride INJECTABLE;INJECTION 020027-001 Oct 24, 1991 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-001 Feb 6, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Apotex DILT-CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076151-003 May 20, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apothecon DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET;ORAL 074051-002 Mar 31, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206534-003 Aug 8, 2017 AB3 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Valeant Pharms North TIAZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020401-004 Sep 11, 1995 AB4 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 206641-001 Aug 11, 2017 AB4 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 075749-001 Nov 21, 2001 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Biovail DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 074845-001 Sep 15, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc CARTIA XT diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 074752-003 Jul 9, 1998 AB3 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-005 Feb 6, 2003 ➤ Subscribe ➤ Subscribe
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-002 May 29, 1992 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-006 Feb 6, 2003 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-001 Aug 10, 1992 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-001 Nov 5, 1982 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-002 Dec 27, 1991 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-004 Dec 27, 1991 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-001 Aug 10, 1992 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-004 Dec 27, 1991 ➤ Subscribe ➤ Subscribe
Valeant Intl CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-004 Dec 27, 1991 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for DILTIAZEM HYDROCHLORIDE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Moodys
AstraZeneca
Dow
Merck
Boehringer Ingelheim
McKesson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot